RxDoctor Payments Data

Tonya Baker

Rheumatology · Knoxville, TNNPI 1508171869

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 532 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 25.6% of the total.

$9,798in general payments, 2019–2025

Across 532 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • Johnson & Johnson$1K
  • Novartis$567
  • UCB, Inc.$489
  • AstraZeneca$444
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$9,27695%
  • Education$5225%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,798 in reported general payments places this provider in the 65th percentile of 127 rheumatology providers in Tennessee.

See all rheumatology providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan13$8,415
Hydroxychloroquine Sulfate46$3,427
Leflunomide15$2,123
Sulfasalazine DrSulfasalazine33$1,746
Leucovorin Calcium12$1,126
MethotrexateMethotrexate Sodium27$971
Gabapentin45$576
Prednisone52$519
Baclofen19$192
Cyclobenzaprine Hcl25$162
Methylprednisolone19$160
Carvedilol11$157
Methotrexate SodiumMethotrexate Sodium/Pf14$139
Spironolactone16$136
Tizanidine Hcl12$135

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$567$8,41513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 127 rheumatology providers in Tennessee.

Other rheumatology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →